Werschler Wm Philip, Few Julius W, Jacob Carolyn I, Joseph John H, Spencer James M, Taub Amy Forman
J Drugs Dermatol. 2016 May 1;15(5):518-25.
Most patients with acne have some degree of facial scarring even after their acne resolves, extending the period of psychosocial distress. Unfortunately, management of acne scars remains challenging. Many treatments for post-acne scarring including chemical peels, skin needling, laser resurfacing, surgical repair, subcision lifting, and punch elevation lifting, are limited by moderate and unpredictable results, significant morbidity, and substantial patient investments in time and money. The most recent addition to the armamentarium is tissue augmentation with soft tissue fillers, including a recently approved polymethylmethacrylate-collagen filler. Matching individual patient needs to the appropriate treatment is crucial. While many patients with acne scars have unrealistic expectations about treatment outcomes, open, honest, and realistic dialogue regarding their treatment options and concerns can facilitate realistic expectations. This article is based on a consensus discussion by the authors, who all have experience managing post-acne scarring, as well as the content of a series of live CME-accredited symposia in connection with major dermatology meetings.
J Drugs Dermatol. 2016;15(5):518-525.
大多数痤疮患者即使在痤疮消退后仍有一定程度的面部瘢痕，这延长了社会心理困扰的时间。不幸的是，痤疮瘢痕的治疗仍然具有挑战性。许多治疗痤疮后瘢痕的方法，包括化学剥脱、皮肤针刺、激光换肤、手术修复、皮下分离提升和打孔提升，都受到效果一般且不可预测、显著的发病率以及患者在时间和金钱上的大量投入的限制。最新加入治疗手段的是使用软组织填充剂进行组织填充，包括一种最近获批的聚甲基丙烯酸甲酯 - 胶原蛋白填充剂。将个体患者的需求与合适的治疗方法相匹配至关重要。虽然许多痤疮瘢痕患者对治疗结果抱有不切实际的期望，但就其治疗选择和担忧进行开放、诚实且现实的对话有助于形成现实的期望。本文基于作者们的共识讨论撰写而成，作者们均有治疗痤疮后瘢痕的经验，同时也参考了与主要皮肤科会议相关的一系列获得继续医学教育认证的现场研讨会的内容。
《皮肤药物学杂志》。2016年；15(5):518 - 525。
